Acknowledgment for Access to Protective Order Material | Sep 2, 2015 | PAPER | PETITIONER |
Acknowledgment for Access to Protective Order Material | Sep 2, 2015 | PAPER | PETITIONER |
Acknowledgment for Access to Protective Order Material | Sep 2, 2015 | PAPER | PETITIONER |
Petitioner Apotex's Notice of Appeal | Jun 18, 2015 | PAPER | PETITIONER |
Decision - Patent Owner's Motions to Seal - 37 CFR 42.1 and 42.54 | Apr 20, 2015 | PAPER | BOARD |
Final Written Decision - 35 USC 318(a) and 37 CFR 42.73 | Apr 20, 2015 | PAPER | BOARD |
Decision Joint Motion for Entry of Default Protective Order | Apr 16, 2015 | PAPER | BOARD |
Updated Mandatory Notice | Mar 12, 2015 | PAPER | PETITIONER |
Updated Mandatory Notice | Mar 11, 2015 | PAPER | PATENT OWNER |
Record of Oral Hearing | Mar 9, 2015 | PAPER | BOARD |
Apotex Demonstrative Exhibits - Private | Jan 22, 2015 | PAPER | PETITIONER |
Apotex Demonstrative Exhibits - Public_Redacted | Jan 22, 2015 | PAPER | PETITIONER |
Amended Apotex Demonstrative Exhibits - Private | Jan 22, 2015 | PAPER | PETITIONER |
Amended Apotex Demonstrative Exhibits - Public_Redacted | Jan 22, 2015 | PAPER | PETITIONER |
Certificate of Service for Apotex Demonstrative Exhibits | Jan 22, 2015 | PAPER | PETITIONER |
Wyeth Amended Demonstrative Exhibits | Jan 22, 2015 | PAPER | PATENT OWNER |
Apotex Objections to Wyeth LLCs Demonstrative Exhibits | Jan 20, 2015 | PAPER | PETITIONER |
Wyeth Objections to Apotex Demonstrative Exhibits | Jan 20, 2015 | PAPER | PATENT OWNER |
Wyeth Demonstrative Exhibits | Jan 15, 2015 | PAPER | PATENT OWNER |
Apotex Exhibit List 1-14-2015 | Jan 14, 2015 | PAPER | PETITIONER |
Apotex Opposition to Motion to Seal 1-14-2015 (Sealed) | Jan 14, 2015 | PAPER | PETITIONER |
Apotex Opposition to Motion to Seal 1-14-2015 (Redacted) | Jan 14, 2015 | PAPER | PETITIONER |
Previously marked Wyeth Ex. 2145 with annotations | Jan 14, 2015 | EXHIBIT | PETITIONER |
Curriculum Vitae of Christian L. Ofslager | Jan 14, 2015 | EXHIBIT | PETITIONER |
FDA correspondence referring to supplemental new drug applications of December 8, 2006 and March 3, 2006 | Jan 14, 2015 | EXHIBIT | PETITIONER |
U.S. Patent Office Interview Slideshow Presentation | Jan 14, 2015 | EXHIBIT | PETITIONER |
U.S. Patent Application Publication No. 2010/0035845 (Feb. 11, 2010, filed Aug. 5, 2009) (Ofslager) | Jan 14, 2015 | EXHIBIT | PETITIONER |
U.S. Patent 7,553,828 (Nelson) | Jan 14, 2015 | EXHIBIT | PETITIONER |
Chemical formula | Jan 14, 2015 | EXHIBIT | PETITIONER |
Tigecycline chemical formula | Jan 14, 2015 | EXHIBIT | PETITIONER |
Previously marked Wyeth 2003 with annotations | Jan 14, 2015 | EXHIBIT | PETITIONER |
Chemical formula | Jan 14, 2015 | EXHIBIT | PETITIONER |
Chemical formula | Jan 14, 2015 | EXHIBIT | PETITIONER |
Chemical formula | Jan 14, 2015 | EXHIBIT | PETITIONER |
Chemical formula | Jan 14, 2015 | EXHIBIT | PETITIONER |
Chemical formula | Jan 14, 2015 | EXHIBIT | PETITIONER |
U.S. Patent 5,399,558 (Baker) | Jan 14, 2015 | EXHIBIT | PETITIONER |
Toxnet HSDB - minocycline | Jan 14, 2015 | EXHIBIT | PETITIONER |
Tigecycline and minocycline chemical formula | Jan 14, 2015 | EXHIBIT | PETITIONER |
Chemical Formula | Jan 14, 2015 | EXHIBIT | PETITIONER |
Tigecycline and albuterol chemical formula | Jan 14, 2015 | EXHIBIT | PETITIONER |
Chemical formula | Jan 14, 2015 | EXHIBIT | PETITIONER |
U.S Patent RE40183 | Jan 14, 2015 | EXHIBIT | PETITIONER |
Apotex Reply to Motion to Exclude | Jan 5, 2015 | PAPER | PETITIONER |
Wyeth Reply ISO Motion to Exclude | Jan 5, 2015 | PAPER | PATENT OWNER |
Apotex Opposition to Motion to Exclude | Dec 29, 2014 | PAPER | PETITIONER |
Apotex Opposition to Motion to Exclude_Public | Dec 29, 2014 | PAPER | PETITIONER |
Apotex Exhibit List | Dec 29, 2014 | PAPER | PETITIONER |
Wyeth Opposition To Petitioner Motion To Exclude | Dec 29, 2014 | PAPER | PATENT OWNER |
Wyeth Exhibit List | Dec 29, 2014 | PAPER | PATENT OWNER |
5-19-2014 Email from Shomaker to Fisher and Kiernan | Dec 29, 2014 | EXHIBIT | PETITIONER |
4-30-2014 and 5-5-2014 Emails Between Burchfiel and Harber | Dec 29, 2014 | EXHIBIT | PETITIONER |
7-3-2014 Email from Ribar to Fisher Kennedy and Kiernan | Dec 29, 2014 | EXHIBIT | PETITIONER |
Declaration of Adam D. Harber | Dec 29, 2014 | EXHIBIT | PATENT OWNER |
Email from Adam Harber | Dec 29, 2014 | EXHIBIT | PATENT OWNER |
Email from Maria Vignone | Dec 29, 2014 | EXHIBIT | PATENT OWNER |
Email from Travis Ribar | Dec 29, 2014 | EXHIBIT | PATENT OWNER |
Email from Travis Ribar | Dec 29, 2014 | EXHIBIT | PATENT OWNER |
Email from Travis Ribar | Dec 29, 2014 | EXHIBIT | PATENT OWNER |
Order Trial Hearing | Dec 18, 2014 | PAPER | BOARD |
Petitioner Motion to Exclude | Dec 15, 2014 | PAPER | PETITIONER |
Petitioner's Exhibit List | Dec 15, 2014 | PAPER | PETITIONER |
Request for Oral Hearing | Dec 15, 2014 | PAPER | PETITIONER |
Wyeth Motion to Seal | Dec 15, 2014 | PAPER | PATENT OWNER |
Wyeth Motion to Exclude | Dec 15, 2014 | PAPER | PATENT OWNER |
Wyeth Request for Oral Argument | Dec 15, 2014 | PAPER | PATENT OWNER |
Wyeth Exhibit List | Dec 15, 2014 | PAPER | PATENT OWNER |
Apotex Objections to Evidence, served July 29, 2014 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Apotex Objections to Evidence, served August 19, 2014 | Dec 15, 2014 | EXHIBIT | PETITIONER |
9-15-2014 Email from Fomenkova to Shackelford | Dec 15, 2014 | EXHIBIT | PETITIONER |
PRPS notifications of July 22 and 23, 2014 | Dec 15, 2014 | EXHIBIT | PETITIONER |
7-23-2014 1201 AM Email from Kennedy to PTAB and Petitioner | Dec 15, 2014 | EXHIBIT | PETITIONER |
7-23-2014 1204 AM Email from Kennedy to PTAB and Petitioner | Dec 15, 2014 | EXHIBIT | PETITIONER |
Transcript of Examination of Dr. Henry Grabowski (Confidential) | Dec 15, 2014 | EXHIBIT | PATENT OWNER |
Transcript of Examination of Dr. Henry Grabowski (Redacted) | Dec 15, 2014 | EXHIBIT | PATENT OWNER |
Transcript of Examination of Mr. Christian Ofslager (Confidential) | Dec 15, 2014 | EXHIBIT | PATENT OWNER |
Transcript of Examination of Mr. Christian Ofslager (Redacted) | Dec 15, 2014 | EXHIBIT | PATENT OWNER |
Transcript of Examination of Dr. Lester Mitscher (Confidential) | Dec 15, 2014 | EXHIBIT | PATENT OWNER |
Transcript of Examination of Dr. Lester Mitscher (Redacted) | Dec 15, 2014 | EXHIBIT | PATENT OWNER |
Transcript of Examination of Dr. Robert Williams (Confidential) | Dec 15, 2014 | EXHIBIT | PATENT OWNER |
Transcript of Examination of Dr. Robert Williams (Redacted) | Dec 15, 2014 | EXHIBIT | PATENT OWNER |
Apotex Reply PUBLIC VERSION | Nov 5, 2014 | PAPER | PETITIONER |
Apotex Reply UNREDACTED | Nov 5, 2014 | PAPER | PETITIONER |
Order - re Conference Call (10/30/2014) | Nov 3, 2014 | PAPER | BOARD |
Notice of Joint Stipulation Regarding Due Date 2 | Oct 29, 2014 | PAPER | PETITIONER |
Notice of Joint Stipulation Regarding Due Date 2 | Oct 22, 2014 | PAPER | PETITIONER |
Apotex Inc.'s Updated Notice of Deposition of Edward O. Gramling, Esq. | Sep 29, 2014 | PAPER | PETITIONER |
Apotex Inc.'s Notice of Deposition of Edward O. Gramling, Esq. | Sep 26, 2014 | PAPER | PETITIONER |
Decision - Motion for Pro Hac Vice Admission | Sep 17, 2014 | PAPER | BOARD |
Wyeth LLC's Exhibit List | Sep 17, 2014 | PAPER | PATENT OWNER |
Transcript of Teleconference | Sep 17, 2014 | EXHIBIT | PATENT OWNER |
Unopposed Motion for Pro Hac Vice Admission of Adam D. Harber | Sep 10, 2014 | PAPER | PATENT OWNER |
Wyeth LLC's Exhibit List | Sep 10, 2014 | PAPER | PATENT OWNER |
Declaration of Adam D. Harber | Sep 10, 2014 | EXHIBIT | PATENT OWNER |
Apotex Inc.'s Updated Notice of Deposition of Lester A. Mitscher, Ph.D. | Sep 9, 2014 | PAPER | PETITIONER |
Apotex Inc.'s Updated Notice of Deposition of Robert O. Williams III, Ph.D. | Sep 9, 2014 | PAPER | PETITIONER |
Apotex Exhibit List | Sep 5, 2014 | PAPER | PETITIONER |
Apotex Inc.'s Notice of Deposition of Henry G. Grabowski, Ph.D. | Sep 5, 2014 | PAPER | PETITIONER |
Apotex Inc.'s Notice of Deposition of Lester A. Mitscher, Ph.D. | Sep 5, 2014 | PAPER | PETITIONER |
Apotex Inc.'s Notice of Deposition of Christian L. Ofslager | Sep 5, 2014 | PAPER | PETITIONER |
Apotex Inc.'s Notice of Deposition of Robert O. Williams III, Ph.D. | Sep 5, 2014 | PAPER | PETITIONER |
Verified Deposition Transcript of Jennifer Brooks | Sep 5, 2014 | EXHIBIT | PETITIONER |
Wyeth LLC's Motion to Seal | Aug 12, 2014 | PAPER | PATENT OWNER |
Wyeth LLC's Exhibit List | Aug 12, 2014 | PAPER | PATENT OWNER |
Supplement to Exhibit 2042 Email dated June 18, 2004 with attachments | Aug 12, 2014 | EXHIBIT | PATENT OWNER |
Supplement to Exhibits 2045 and 2065 Email dated August 26, 2004 with attachments | Aug 12, 2014 | EXHIBIT | PATENT OWNER |
Supplement to Exhibit 2046 Email dated June 12, 2008 with attachments | Aug 12, 2014 | EXHIBIT | PATENT OWNER |
Supplement to Exhibit 2047 Email dated July 28, 2004 with attachments | Aug 12, 2014 | EXHIBIT | PATENT OWNER |
Supplement to Exhibit 2048 Email dated July 15, 2004 with attachments | Aug 12, 2014 | EXHIBIT | PATENT OWNER |
Supplement to Exhibit 2053 Email dated July 22, 2004 with attachments | Aug 12, 2014 | EXHIBIT | PATENT OWNER |
Supplement to Exhibit 2056 Email dated Sept. 20, 2004 with attachments | Aug 12, 2014 | EXHIBIT | PATENT OWNER |
Supplement to Exhibit 2057 Email dated Aug. 18, 2004 with attachments | Aug 12, 2014 | EXHIBIT | PATENT OWNER |
Supplement to Exhibit 2060 Email dated Sept. 13, 2004 with attachments | Aug 12, 2014 | EXHIBIT | PATENT OWNER |
Supplement to Exhibit 2061 Email dated Sept. 20, 2004 with attachments | Aug 12, 2014 | EXHIBIT | PATENT OWNER |
Supplement to Exhibit 2063 Email dated November 3, 2006 with attachments | Aug 12, 2014 | EXHIBIT | PATENT OWNER |
Supplement to Exhibit 2069 Email dated Sept. 8, 2004 with attachments | Aug 12, 2014 | EXHIBIT | PATENT OWNER |
Supplement to Exhibit 2075 Email dated Sept. 17, 2004 with attachments | Aug 12, 2014 | EXHIBIT | PATENT OWNER |
Supplement to Exhibit 2085 Email dated September 21, 2005 with attachments | Aug 12, 2014 | EXHIBIT | PATENT OWNER |
Supplemental Declaration of Christian L. Ofslager | Aug 12, 2014 | EXHIBIT | PATENT OWNER |
Declaration of Edward O. Gramling, Esq. | Aug 12, 2014 | EXHIBIT | PATENT OWNER |
Power of Attorney | Aug 5, 2014 | PAPER | PATENT OWNER |
Wyeth Exhibit List | Jul 28, 2014 | PAPER | PATENT OWNER |
Transcript of July 15, 2014 Teleconference | Jul 28, 2014 | EXHIBIT | PATENT OWNER |
Wyeth Exhibit List | Jul 23, 2014 | PAPER | PATENT OWNER |
828 File History (1 of 2) | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
828 File History (2 of 2) | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Email dated June 23, 2004 (WT02139465) | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Email dated June 18, 2004 (WT02093189) | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Email dated July 7, 2004 (WT02125975) and attachments (WT02125976, WT02125980) | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Second Generation Tigecycline 50mgvial Drug Product (SPN- 05-07) Statistical Analyses of Strength and Degradants Stability Samples Stored at 25C/60RH for up to 36 Months (WT02131599) | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Email dated August 26, 2004 (WT02095229) | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Email dated June 12, 2008 (WT02131596) | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Email dated July 28, 2004 (WT02125814) | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Email dated July 15, 2004 (WT02105847) | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Email dated July 25, 2004 (WT02141872) | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Email dated July 27, 2004 (WT02144713) | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Meeting Minutes of Tigecycline Impurity Study Meeting of 11 Aug 2004 (WT02145066) | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Email dated July 14, 2004 (WT02093366) | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Email dated July 22, 2004 (WT02141859) and attachment (WT02141861) | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Email dated Aug. 19, 2004 (WT02130756) and attachment (WT02130756) | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Email dated Aug. 25, 2004 (WT02130986) and attachment (WT02130987) | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Email dated Sept. 20, 2004 (WT02097293) | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Email dated Aug. 18, 2004 (WT02130647) | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Presentation dated August 24, 2004 (WT02134121) | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Email dated Sept. 9, 2004 (WT02146678) and attachment (WT02146679) | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Email dated Sept. 13, 2004 (WT02095373) | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Email dated Sept. 20, 2004 (WT02147238) | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Email dated Sept. 20, 2004 (WT02134686) and attachment (GAR-936 Second Generation, WT02135084) | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Email dated November 3, 2006 (WT02152359) and attachment (WT02152365) | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Email dated Sept. 21, 2004 and attachment (WT02106476) | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Email dated Aug. 26, 2004 (WT02095229) | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Email dated Feb. 4, 2005 (WT02104636) | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Email dated Sept. 7, 2004 (WT02095350) and attachment (WT02095352) | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Email dated September 7, 2004 (WT02105925) | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Email dated Sept. 8, 2004 (WT02146673) | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Email dated Oct. 28, 2004 (WT02098319) with attachment (WT02098321) | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Email dated February 17, 2005 (WT02161628) and attachment (WT02161629) | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Email dated Oct. 5, 2004 (WT02108194) | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Email dated Sept. 16, 2004 (WT02106381) | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Email dated Sept. 22, 2004 (WT02135165) | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Email dated Sept. 17, 2004 (WT02147206) | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Report of Up to Twenty Four Months Stability Data for Tigecycline for Injection, 50 mgVial in Flint Glass Vials with Document Number RPT-53256 | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Report of Up to Thirty Six Months Stability Data for Second Generation Tigecycline for Injection, 50 mg Vial in Flint Glass Vials (US submission) with Document Number RPT-61731 | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Lab Notebook No. 27787 (excerpts) | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Lab Notebook No. 27786 (excerpts) | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Email dated October 13, 2004 (WT02097705) and attachment (WT02097706) | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Tigecycline 50mgvial Drug Product (SPN 03-13 SPN 03-37) Statistical Analyses of Strength and Degradants Stability Samples Stored At 25C/60RH For Up To 18 Months) WT02244857 | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Email dated Nov. 2004 (WT02096836) and attachment (WT02096837) | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Tigecycline 50mgvial Drug Product (SPN 03-13 SPN 03-37) Statistical Analyses of Strength and Degradants Stability Samples Stored At 30C/70RH For Up To 18 Months (WT02244827) | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Email dated November 17, 2004 (WT02111448) and attachments (WT02111449, presentation and WT02111477, data) | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Email dated September 21, 2005 (WT02244825) | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Email dated April 8, 2008 (WT02121634) and attachment (WT02121635) | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Email dated Sept. 9, 2004 (WT02146678) and attachments (WT02146679 and WT02146680) | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Curriculum Vitae of Lester A. Mitscher | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Patricia A. Bradford, Tigecycline A First in Class Glycylcycline, 26 21 Clinical Microbiology Newsletter 163 (Nov. 1, 2004) | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
430 pH Meter Instruction Manual, Corning Inc. (1992) | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Albert P. Doerschuk et al., Reversible Isomerizations in the Tetracycline Family, 77 J. Amer. Chem. Soc. 4687 (1955) | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
J.R.D. McCormick et al., On the Nature of the Reversible Isomerizations Occurring in the Tetracycline Family, 79 J. Amer. Chem. Soc. 3547 (1957) | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
M. G. Ryadnov et al., Suppression of Epimerization by Cupric (II) Salts in Peptide Synthesis Using Free Amino Acids as Amino Components, 53 J. Peptide Res. 322 (1999) | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
NCCLS, Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Crow Aerobically Approved Standard Sixth Edition Jan. 2003 Vol. 23, No. 2 | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
V. Naggar et al., Solubilization of Tetracycline and Oxytetracycline, 29 Pharmazie 122 (1974) | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Robert G. Strickley, Solubilizing Excipients in Oral and Injectable Formulations, 21 2 Pharmaceutical Research, 201 (February 2004) | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
J.J. Stezowski, 99 J. Am. Chem. Soc. 1122-1129 (1977) | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
David D. Wirth, et al., Maillard Reaction of Lactose and Fluoxetine Hydrochloride, a Secondary Amine, 87 1 Journal of Pharmaceutical Sciences 31 (January 1998) | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Stephen R. Byrn, et al., Chemical reactivity in solid-state pharmaceuticals formulation implications, 48 Advanced Drug Delivery Reviews 115 at 130 (2001) | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
R. L. Willer et al., New chemistry from the reaction of N,N-disubstituted ethylenediamines with glyoxal synthesis of 2-imidazolidinecarboxaldehydes and 1,4,6,9-tetraaa-5,10-dioxaperhydroanthracenes, 50 J. Organic Chem. 2368-2372 (1985). | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
U.S. Patent No. 8,513,224 | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
U.S. Patent No. 8,252,946 | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
U.S. Patent No. 8,207,361 | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
U.S. Patent No. 8,198,469 | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
U.S. Patent No. 8,198,470 | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
U.S. Patent No. 7,871,993 | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
S. I. F. S. Martins, W. M. F. Jongen and M. A. J. S. van Boekel (2001). A review of Maillard reaction in food and implications to kinetic modeling. Trends in Food Science and Technology, 11 364-373 | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Bruce H. Mahan, University Chemistry at 126 (Addison-Wesley Publishing Company, Inc. 1965). | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Curriculum Vitae of Henry Grabowski, Ph.D. | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Annotated Bibliography | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
FDA Approval Letter for NDA 21-821, dated June 15, 2005 | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
FDA Approval Letter for NDA 21-821, dated March 20, 2009 | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Tygacil 2006 Global Brand Plan, June 30, 2005, WT00882959 3013 | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
A Powerful Partner, June, 2007, WT01587097 126 | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
FDA Grants Tygacil (Tigecycline) NDA Priority Review Status, PRNewswire, January 28, 2005 | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Fast Track, Breakthrough Therapy, Accelerated Approval and Priority Review Expediting Availability of New Drugs for Patients with Serious Conditions | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Statement of Jane E. Henney, M.D., Commissioner, Food and Drug Administration, Department of Health and Human Services, Antimicrobial Resistance, United States Senate Hearing before a Subcommittee of the Committee of Appropriations, September 20, 2000 | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Harper, G. L., 2013, Antibiotic Formulary Guidelines for Health Systems Balancing Evidence and Stewardship, Formulary, Vol. 48, pp. 332 338 | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Powers, J. H., 2004, Antimicrobial Drug Development the Past, the Present, and the Future, Clinical Microbiology and Infection, Vol. 10, Supp. 4, pp. 23 31 | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Mossialos, E. et al., Policies and Incentives for Promoting Innovation in Antibiotic Research, The London School of Economics and Political Science | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
FDA Task Force on Antimicrobial Resistance Key Recommendations and Report, December 5, 2000 | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Tygacil Diagnostic and Strategic Pricing Alignment, April 24, 2007, WT01888512 549 | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
PMT Tygacil Revenue Review, June 5, 2008, WT00581424 485 | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
20072008 Relationship Marketing Plan, May 2007, WT01589088 125 | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Arlington Medical Research, Cost Considerations and Pathogen Coverage for Antibiotics are the Most Important Factors that Influence Hospital Formulary Decision Marking | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
TYGACIL 2014 Op Plan, August 7, 2013 | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Tygacil Value Proposition and Pricing Contracting Strategy Evaluation, September 21, 2010, WT00297434 485 | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Rai, J., G. Randhawa, and M. Kaur, 2013, Recent Advances in Antibacterial Drugs, International Journal of Applied and Basic Medical Research, Vol. 3, No. 1, pp. 3 10 | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Tygacil Specialty Promotional Materials Testing, August 26, 2010, WT00296321 360 | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
TYGACIL Drug Label, revised September 26, 2013 | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Transmittal of Advertisements and Promotional Labeling for Drugs and Biologics for Human Use Form, June 19, 2007, WT00136250 277 | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
2009 Annual Written Marketing Plan U.S. Tygacil, December 18, 2008, WT00567248 278 | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Thomas, J., 2012, Patent Infringement and Experimental Use Under the Hatch-Waxman Act Current Issues, Congressional Research Service, at p. 1. | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Azoulay, P., 2002, Do Pharmaceutical Sales Respond to Scientific Evidence, Journal of Economics Management Strategy, Vol. 11, No. 4, pp. 551 594 | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Berndt, E. R., et al., 2002, An Analysis of the Diffusion of New Antidepressants Variety, Quality, and Marketing Efforts, The Journal of Mental Health Policy and Economics, Vol. 5, pp. 3 19 | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Iizuka, T., 2004, What Explains the Use of Direct-to-Consumer Advertising of Prescription Drugs, The Journal of Industrial Economics, Vol. 52, No. 3, pp. 349 379 | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Leffler, K. B., 1981, Persuasion or Information, The Economics of Prescription Drug Advertising, Journal of Law and Economics, Vol. 24, No. 1, pp. 45 74 | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Venkataraman, S. and S. Stremersch, 2007, The Debate on Influencing Doctors Decision Are Drug Characteristics the Missing Link, Management Science, Vol. 53, No. 11, pp. 1688 1701 | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Berndt, E. R., 2001, The U.S. Pharmaceutical Industry Why Major Growth in Times of Cost Containment, Health Affairs, Vol. 20, No. 2, pp. 100 114 | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Berndt, E. R., 2002, Pharmaceuticals in U.S. Health Care Determinants of Quantity and Price, Journal of Economic Perspectives, Vol. 16, No. 4, pp. 45 66 | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Coscelli, A. and M. Shum, 2004, An Empirical Model of Learning and Patient Spillovers in New Drug Entry, Journal of Econometrics, Vol. 122, pp. 213 246 | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
2007 TYGACIL Global/US Marketing Plan, January 15, 2007, WT01888349 419 | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Grabowski H., and J. Vernon, 1990, A New Look at the Returns and Risks to Pharmaceutical RD, Management Science, Vol. 36, No. 7, pp. 804 821 at p. 813 | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
TYGACIL Wholesale Dollar Sales 2005-2013 | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
TYGACIL Eaches 2005 2013 | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Information for Systemic Antibiotic Drugs Approved Since 2001 | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
TYGACIL and Competitor Drugs Wholesale Dollar Sales by Years Since Launch | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
TYGACIL Q1 Wholesale Dollar Sales 2011 2014 | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
TYGACIL Promotional Spending 2005 2013 | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
TYGACIL and Competitor Drugs Promotional Spending to Wholesale Dollar Sales Ratio By Year Since Launch | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Henry Grabowski Documents Relied Upon | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Complete Deposition Transcript of Jennifer Brooks (July 9, 2014) | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
Default Protective Order | Jul 23, 2014 | EXHIBIT | PATENT OWNER |
PATENT OWNER WYETH LLC RESPONSE | Jul 22, 2014 | PAPER | PATENT OWNER |
Motion to Seal | Jul 22, 2014 | PAPER | PATENT OWNER |
Joint Motion for Entry of Default Protective Order | Jul 22, 2014 | PAPER | PATENT OWNER |
Chemical Structure (Nelson Deposition) | Jul 22, 2014 | EXHIBIT | PATENT OWNER |
PROZ.com Bio of Jennifer Brooks (Brooks Deposition) | Jul 22, 2014 | EXHIBIT | PATENT OWNER |
PROZ.com Search Results (Brooks Deposition) | Jul 22, 2014 | EXHIBIT | PATENT OWNER |
PROZ.com Bio of Chinese to English Translator (Brooks Deposition) | Jul 22, 2014 | EXHIBIT | PATENT OWNER |
PROZ.com Bio of Chinese to English Translator (Brooks Deposition) | Jul 22, 2014 | EXHIBIT | PATENT OWNER |
Expert Declaration of Lester A. Mitscher, Ph.D. | Jul 22, 2014 | EXHIBIT | PATENT OWNER |
Expert Declaration of Robert O. Williams III, Ph.D. | Jul 22, 2014 | EXHIBIT | PATENT OWNER |
Expert Declaration of Henry Grabowski, Ph.D. | Jul 22, 2014 | EXHIBIT | PATENT OWNER |
Declaration of Christian L. Ofslager | Jul 22, 2014 | EXHIBIT | PATENT OWNER |
Complete Deposition Transcript of Mark L. Nelson, Ph.D. (June 4, 2014) | Jul 22, 2014 | EXHIBIT | PATENT OWNER |
Curriculum Vitae of Robert O. Williams III, Ph.D. | Jul 22, 2014 | EXHIBIT | PATENT OWNER |
Handbook of Pharmaceutical Excipients (Ainley Wade et al. eds., 2d ed. 1994) | Jul 22, 2014 | EXHIBIT | PATENT OWNER |
Patrick Crowley et al., Drug-Excipient Interactions, Pharm. Tech. (2001) | Jul 22, 2014 | EXHIBIT | PATENT OWNER |
Reformulated Tygacil Label | Jul 22, 2014 | EXHIBIT | PATENT OWNER |
Original Tygacil Label | Jul 22, 2014 | EXHIBIT | PATENT OWNER |
Avis, Pharmaceutical Dosage Forms Parenteral Medications (2d ed. 1992) | Jul 22, 2014 | EXHIBIT | PATENT OWNER |
Drug Stability Principles and Practices (Carstensen, 3d ed. 2000) | Jul 22, 2014 | EXHIBIT | PATENT OWNER |
Remington (Gennaro, 17th ed. 1985) | Jul 22, 2014 | EXHIBIT | PATENT OWNER |
Guide to Inspections of Lyophilization of Parenterals | Jul 22, 2014 | EXHIBIT | PATENT OWNER |
Sandeep Nema et al., Excipients and Their Use in Injectable Products, 51 PDA J. Pharm. Sci. Tech. 166 (1997) | Jul 22, 2014 | EXHIBIT | PATENT OWNER |
U.S. Patent No. 4,418,060 | Jul 22, 2014 | EXHIBIT | PATENT OWNER |
U.S. Patent No. 4,081,528 | Jul 22, 2014 | EXHIBIT | PATENT OWNER |
U.S. Patent No. 4,376,118 | Jul 22, 2014 | EXHIBIT | PATENT OWNER |
Pharmaceutical Development Report (WT02083619) | Jul 22, 2014 | EXHIBIT | PATENT OWNER |
Protein Formulation and Delivery (Eugene J. McNally ed., 2000) | Jul 22, 2014 | EXHIBIT | PATENT OWNER |
Email dated Aug. 31, 2004 (WT02095310) | Jul 22, 2014 | EXHIBIT | PATENT OWNER |
Gopal Muralidharan et al., Pharmacokinetics of Tigecycline after Single and Multiple Doses in Healthy Subjects, 49 Antimicrobial Agents Chemotherpay 220 (2005) | Jul 22, 2014 | EXHIBIT | PATENT OWNER |
George C. Zhanel et al., The Glycylcyclines A Comparative Review with the Tetracyclines, Drugs (2004) | Jul 22, 2014 | EXHIBIT | PATENT OWNER |
Physicians Desk Reference (Minocin, 1996) | Jul 22, 2014 | EXHIBIT | PATENT OWNER |
U.S. Patent No. 3,026,248 | Jul 22, 2014 | EXHIBIT | PATENT OWNER |
U.S. Patent No. 4,701,320 | Jul 22, 2014 | EXHIBIT | PATENT OWNER |
Tygacil Complaint History (WT00145482) | Jul 22, 2014 | EXHIBIT | PATENT OWNER |
Tygacil Formulation Comparison (WT01598062) | Jul 22, 2014 | EXHIBIT | PATENT OWNER |
Report of Up to Twenty Four Months Stability Data for Tigecycline for Injection, 50mgVial in Flint Glass Vials (RPT-53256) (WT00144819) | Jul 22, 2014 | EXHIBIT | PATENT OWNER |
Report of Up to Thirty Six Months Stability Data for Second Generation Tigecycline for Injection, 50 mgvial in Flint Glass Vials (US Submission) (RPT-61731) (WT02114474) | Jul 22, 2014 | EXHIBIT | PATENT OWNER |
Evaluation of Antioxidants for GAR 936 (RPT-49190) (WT02257784) | Jul 22, 2014 | EXHIBIT | PATENT OWNER |
Development Pharmaceuticals Report for Tigecycline (RPT-54471) | Jul 22, 2014 | EXHIBIT | PATENT OWNER |
Berndt, E. R., 2002, Pharmaceuticals in U.S. Health Care Determinants of Quantity and Price, Journal of Economic Perspectives, Vol. 16, No. 4 | Jul 22, 2014 | EXHIBIT | PATENT OWNER |
ORDER Conduct of the Proceeding | Jul 21, 2014 | PAPER | BOARD |
Apotex Exhibit List | Jul 21, 2014 | PAPER | PETITIONER |
Verified Deposition Transcript of Mark L. Nelson, Ph. D | Jul 21, 2014 | EXHIBIT | PETITIONER |
Declaration of Raja Saliba re Exhibit 1005 | Jul 15, 2014 | PAPER | PETITIONER |
Updated Exhibit List | Jul 15, 2014 | PAPER | PETITIONER |
Declaration of Raja Saliba | Jul 15, 2014 | EXHIBIT | PETITIONER |
Order - Conduct of the Proceeding - 37 CFR 42.5 | Jul 14, 2014 | PAPER | BOARD |
Updated Mandatory Notice | Jul 7, 2014 | PAPER | PETITIONER |
Power of Attorney | Jul 7, 2014 | PAPER | PETITIONER |
Exhibit List | Jul 7, 2014 | PAPER | PETITIONER |
Replacement Translation | Jul 7, 2014 | EXHIBIT | PETITIONER |
Replacement Declaration | Jul 7, 2014 | EXHIBIT | PETITIONER |
Order - re Conference Call (6/23/2014) | Jul 1, 2014 | PAPER | BOARD |
Amended Notice of Deposition of Jennifer Brooks | Jun 26, 2014 | PAPER | PATENT OWNER |
Notice of Deposition of Jennifer Brooks | Jun 24, 2014 | PAPER | PATENT OWNER |
Power of Attorney | Jun 4, 2014 | PAPER | PATENT OWNER |
Power of Attorney | Jun 4, 2014 | PAPER | PATENT OWNER |
Notice of Additional Backup Counsel | Jun 4, 2014 | PAPER | PATENT OWNER |
Order - Conduct of the Proceeding | May 29, 2014 | PAPER | BOARD |
Decision - Motion for Pro Hac Vice Admission | May 29, 2014 | PAPER | BOARD |
Decision - Motion for Pro Hac Vice Admission | May 29, 2014 | PAPER | BOARD |
Wyeth's List of Motions | May 20, 2014 | PAPER | PATENT OWNER |
Expunged | May 20, 2014 | PAPER | PETITIONER |
Petitioner's Exhibit List | May 20, 2014 | PAPER | PETITIONER |
Notice of Allowability in U.S. Patent Application No. 11/374,330 | May 20, 2014 | EXHIBIT | PETITIONER |
Wyeth v. Sandoz - Report dated February 3, 2012 | May 20, 2014 | EXHIBIT | PETITIONER |
Wyeth v. Sandoz - Order dated March 1, 2012 | May 20, 2014 | EXHIBIT | PETITIONER |
Wyeth v. Sandoz Joint Pretrial Order Exhibits including contested facts and law | May 20, 2014 | EXHIBIT | PETITIONER |
Response to Notice of Non-Compliant Amendment of January 21, 2011, U.S. Patent Application No. 13/011,164, | May 20, 2014 | EXHIBIT | PETITIONER |
Office Action of March 13, 2014, U.S. Patent Application No. 13/011,164 | May 20, 2014 | EXHIBIT | PETITIONER |
Election of Species of February 17, 2014, U.S. Patent Application No. 13/011,164 | May 20, 2014 | EXHIBIT | PETITIONER |
Notice of Deposition of Mark L. Nelson, Ph.D. | May 19, 2014 | PAPER | PATENT OWNER |
Motion for Pro Hac Vice Admission of David I. Berl | May 15, 2014 | PAPER | PATENT OWNER |
Motion for Pro Hac Vice Admission of Thomas H. L. Selby | May 15, 2014 | PAPER | PATENT OWNER |
Wyeth's Exhibit List as of May 15, 2014 | May 15, 2014 | PAPER | PATENT OWNER |
Declaration of David I. Berl | May 15, 2014 | EXHIBIT | PATENT OWNER |
Declaration of Thomas H. L. Selby | May 15, 2014 | EXHIBIT | PATENT OWNER |
Decision - Institution of Inter Partes Review | Apr 21, 2014 | PAPER | BOARD |
Scheduling Order | Apr 21, 2014 | PAPER | BOARD |
Waiver of Patent Owner Preliminary Response | Feb 7, 2014 | PAPER | PATENT OWNER |
Power of Attorney | Nov 22, 2013 | PAPER | INDICATES ARTIFACT WAS SUBMITTED ON BEHALF OF POTENTIAL_PATENT OWNER. |
Related Matters | Nov 22, 2013 | PAPER | INDICATES ARTIFACT WAS SUBMITTED ON BEHALF OF POTENTIAL_PATENT OWNER. |
Notice of Filing Date Accorded to Petition | Nov 7, 2013 | PAPER | BOARD |
Inter Partes Review Petition of US 7879828 | Nov 1, 2013 | PAPER | PETITIONER |
Power of Attorney | Nov 1, 2013 | PAPER | PETITIONER |
Exhibit List | Nov 1, 2013 | PAPER | PETITIONER |
Certificate of Service for Power of Attorney | Nov 1, 2013 | PAPER | PETITIONER |
Power of Attorney | Nov 1, 2013 | PAPER | PETITIONER |
US Patent No. 7879828 | Nov 1, 2013 | EXHIBIT | PETITIONER |
Nelson Declaration | Nov 1, 2013 | EXHIBIT | PETITIONER |
CN 1390550 | Nov 1, 2013 | EXHIBIT | PETITIONER |
CN 1390550 Translation | Nov 1, 2013 | EXHIBIT | PETITIONER |
Brooks Declaration | Nov 1, 2013 | EXHIBIT | PETITIONER |
Pawelczyk | Nov 1, 2013 | EXHIBIT | PETITIONER |
Naggar | Nov 1, 2013 | EXHIBIT | PETITIONER |
Remmers | Nov 1, 2013 | EXHIBIT | PETITIONER |
Ritter | Nov 1, 2013 | EXHIBIT | PETITIONER |
Hill | Nov 1, 2013 | EXHIBIT | PETITIONER |
Trivedi | Nov 1, 2013 | EXHIBIT | PETITIONER |
Geneidi | Nov 1, 2013 | EXHIBIT | PETITIONER |
Kreilgard | Nov 1, 2013 | EXHIBIT | PETITIONER |
Kreilgard Translation | Nov 1, 2013 | EXHIBIT | PETITIONER |
Schoenberg Declaration | Nov 1, 2013 | EXHIBIT | PETITIONER |
Pastia | Nov 1, 2013 | EXHIBIT | PETITIONER |
Pastia Translation | Nov 1, 2013 | EXHIBIT | PETITIONER |
Hoble Declaration | Nov 1, 2013 | EXHIBIT | PETITIONER |
Lawter | Nov 1, 2013 | EXHIBIT | PETITIONER |
Nelson - Chemistry of Tetracyclines | Nov 1, 2013 | EXHIBIT | PETITIONER |
Schneider | Nov 1, 2013 | EXHIBIT | PETITIONER |
Kirsch | Nov 1, 2013 | EXHIBIT | PETITIONER |
Herman | Nov 1, 2013 | EXHIBIT | PETITIONER |
Zhang | Nov 1, 2013 | EXHIBIT | PETITIONER |
Bedu-Addo lyophilization | Nov 1, 2013 | EXHIBIT | PETITIONER |
CDER 21-821 | Nov 1, 2013 | EXHIBIT | PETITIONER |
Dextrose Injection | Nov 1, 2013 | EXHIBIT | PETITIONER |
Sodium Chloride Injection | Nov 1, 2013 | EXHIBIT | PETITIONER |
Braun 0.9 Saline | Nov 1, 2013 | EXHIBIT | PETITIONER |
Braun 5% Dextrose Label | Nov 1, 2013 | EXHIBIT | PETITIONER |
Yu Hang | Nov 1, 2013 | EXHIBIT | PETITIONER |
Testa | Nov 1, 2013 | EXHIBIT | PETITIONER |
Moreno-Cerezo | Nov 1, 2013 | EXHIBIT | PETITIONER |
IDS | Nov 1, 2013 | EXHIBIT | PETITIONER |
Final Office Action | Nov 1, 2013 | EXHIBIT | PETITIONER |
Interview Summary Record | Nov 1, 2013 | EXHIBIT | PETITIONER |
Amendment and Response | Nov 1, 2013 | EXHIBIT | PETITIONER |
Ofslager Declaration | Nov 1, 2013 | EXHIBIT | PETITIONER |